aspirin: be recommended for diabetes

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.67
, medication
Weight: 0.66
, substance
Weight: 0.64
, ingredient
Weight: 0.62
, item
Weight: 0.61
Siblings ibuprofen
Weight: 0.38
, acetaminophen
Weight: 0.38
, warfarin
Weight: 0.37
, naproxen
Weight: 0.37
, acne medication
Weight: 0.36

Related properties

Property Similarity
be recommended for diabetes 1.00
be recommended in pregnancy 0.84
reduce cancer risk 0.76
affect asthma 0.76
be used in kawasaki disease 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.59
Similarity weight: 0.76
Evidence: 0.56
¬ Remarkable(aspirin, be recommended for diabetes) ⋁
Evidence: 0.74
¬ Remarkable(ibuprofen, affect asthma)

Remarkability from sibling implausibility

0.45
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.74
Remarkable(ibuprofen, affect asthma) ⋁
Evidence: 0.65
¬ Plausible(ibuprofen, affect asthma)

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.99
¬ Salient(aspirin, be recommended for diabetes)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.84
Evidence: 0.99
Typical(aspirin, be recommended for diabetes) ⋁
Evidence: 0.94
¬ Typical(aspirin, be recommended in pregnancy)
0.71
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.84
Evidence: 0.99
Salient(aspirin, be recommended for diabetes) ⋁
Evidence: 0.77
¬ Salient(aspirin, be recommended in pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.84
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.82
¬ Plausible(aspirin, be recommended in pregnancy)
0.64
Rule weight: 0.85
Evidence weight: 1.00
Similarity weight: 0.76
Evidence: 0.99
Typical(aspirin, be recommended for diabetes) ⋁
Evidence: 0.70
¬ Typical(aspirin, affect asthma)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.99
Typical(aspirin, be recommended for diabetes) ⋁
Evidence: 0.96
¬ Typical(aspirin, reduce cancer risk)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.99
Typical(aspirin, be recommended for diabetes) ⋁
Evidence: 0.78
¬ Typical(aspirin, be used in kawasaki disease)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.99
Salient(aspirin, be recommended for diabetes) ⋁
Evidence: 0.58
¬ Salient(aspirin, be used in kawasaki disease)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.99
Salient(aspirin, be recommended for diabetes) ⋁
Evidence: 0.87
¬ Salient(aspirin, reduce cancer risk)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.99
Salient(aspirin, be recommended for diabetes) ⋁
Evidence: 0.87
¬ Salient(aspirin, affect asthma)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.64
¬ Plausible(aspirin, be used in kawasaki disease)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.74
¬ Plausible(aspirin, affect asthma)
0.62
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.88
¬ Plausible(aspirin, reduce cancer risk)
0.60
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.84
Evidence: 0.56
Remarkable(aspirin, be recommended for diabetes) ⋁
Evidence: 0.37
¬ Remarkable(aspirin, be recommended in pregnancy)
0.54
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.56
Remarkable(aspirin, be recommended for diabetes) ⋁
Evidence: 0.38
¬ Remarkable(aspirin, be used in kawasaki disease)
0.52
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.76
Evidence: 0.56
Remarkable(aspirin, be recommended for diabetes) ⋁
Evidence: 0.44
¬ Remarkable(aspirin, reduce cancer risk)
0.42
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.76
Evidence: 0.56
Remarkable(aspirin, be recommended for diabetes) ⋁
Evidence: 0.80
¬ Remarkable(aspirin, affect asthma)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.99
Salient(aspirin, be recommended for diabetes) ⋁
Evidence: 0.99
¬ Typical(aspirin, be recommended for diabetes) ⋁
Evidence: 0.56
¬ Remarkable(aspirin, be recommended for diabetes)

Typical implies Plausible

0.46
Rule weight: 0.48
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.96
Plausible(aspirin, be recommended for diabetes) ⋁
Evidence: 0.99
¬ Typical(aspirin, be recommended for diabetes)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.56
¬ Remarkable(aspirin, be recommended for diabetes) ⋁
Evidence: 0.64
¬ Typical(ibuprofen, affect asthma)